<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Effect of teplizumab on development of clinical (stage 3) type 1 diabetes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Effect of teplizumab on development of clinical (stage 3) type 1 diabetes</h1>
<div class="graphic"><div class="figure"><div class="ttl">Effect of teplizumab on development of clinical (stage 3) type 1 diabetes</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAA6IAAAJVBAMAAAA2NlWhAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAJ1BMVEX///8AAABiicDFUDbo6OgZGRmIiIhMTEzFxMSioqIzMzN3d3dmZmZX077AAAAccUlEQVR42uzdT2sbSRoG8IrT6lZLOswLqm5J9sH4EwT8BSSwx4kzBzXIm3jIoQVOJtnsQQ3ODJmTBBOcnVzUEDPs7MUNZjcLe5BhsyQ7Fwn2H8N+qK0qyY5sy4okt+zu9vOYGGLiVqSf6+2qt1tlxhAEQRAEQRAEQRAEQRAEQRAEQRAEQRDkxsWXn+qlMl6JhCRF4lO6YDTwUiQlLfFHb6SreCWSJJrranm8EskTzZLIymezfM3/YUp2wqq65qDq3oq+6BeJHmC3QhG1Ps2MTh1wddS/X4BotEVTZDPr0+oFovEfo2MOOK3o1WBDFKIQhShEIQpRiEZHdPxqFaIQheg1i47JwvJV1N35iWasUV+tFC552MAd8UWNmhCdg+hRMV0aJ+q5gTssetSY5KgmdVL5MaKGlbGuSXR19U7CRfnd0vgxOptoYayofCSIzknU+W/J5Gn6suT9xTvM2M6u6djl4F8HrFWtiA/vG6LKotNQX3W9vxO1JxHlpVTer7byrQf8J94OXtjlPdrOLH3NmNMUH3uWR3l6b1+9KGO370z37Qsry/ESfWwNRHMlUQsXDavVqDcCOmCpQr3gd1XVLa4X/Kp/IEQ7E45RO3jcF635NXG4jrezdZdnSJQD7ynt8H7Vfes0IRq+6BPeF7Wz4iNj6XaPqCrLZM76/lGv3T+Ppoq9biU/jWhrqy9aFT8K4nD1l0T0o6zp/rdfby8OzqNOG6Lhi7rBWdFu/8Rn2r95scVmFc3SGVE+OEuvP/jWLkB0nqKtkkb3TkQzlv/QbKipjFOo20LUU6Ky6va6Qac+oShz8pW8fyIa7DjuxqYUNegpVQ3LiInowpU0GcIVzZZYb+lYlFPHDMhVol61UhSi+yRF5czolR10NiebGdnMz+eodyzqLLI9stUY1QVk17BMJw9R9IyupeqymFVdiEIUohCF6JWIeu7pv6cubscPeoMXte0GMc52EJ2L//mgLTjyEkB8RBeWIyaqXnHdHhI9+wqn+UC0VR0SHX2BRoj2fyhO1jfi+Od+CNSBhOhTPix6qu87d9HVaReksRE9P0bPijp81Bi9UPT8GD0rmqLqqDEK0Usf4WcqiDH6e96zxBjt0S7RrhR16M9WmvsPqK2TfTxGNY+LMerToka9JbZPux7l92g77dGQg1jE7okx6j8it97IkV0huyxEU1Ty3NY294qsTo3jMbpBzlNuEnUqS9QVC90Norseb++RdRWi0zeNYiCa5mWmRO9x3TYW5QBb6o9Rs5Sz/FqrWnflGFaismMnIDTnLb11Xtu6nbG0rbs8VTxVTWuq6vo1v1pveB1ZA7r9Meof9J7xu1y31BhWop6rqu56UV4CUBcG3HXxmIN+A0RnSHaJ9UVlP7eSZ+wx2YOq67wSKKmCQ3JIKdFKXoreJ9qhpvc7Ip6xxPiiV/Tv4dZTty9abeXru1RmukONvmiqsHWPi8OSGvVSVKOyENWOyKoUDKt/YcAnKjhLbjRF538TUuiieun+sWjd6SrR9snMqC/qNQIluiTPo6b4uvYP6l4sWj88GojqfMmUosWTmVFf1BBjXYl25XnUF1+/HyxB9LJVV4qKqpu1DSUq/lREnaz61aNDvTMQzVgpIRrsODv0g/iW5k+GpTnuRpn1uuerrhSVVfeo4UlRMTvSqGByk2dL5efHVTdwxXk0Y60L0fWCvDDgueuWtsty0RQdW44jInoyM5KimpgZBSUlqtOBYTN/q9TUHd6WMyVxjk07W0J0nwtRZ1t8p2yy7/XnPudnRkr0K7I3KVCi9RLzGiZ33onCvi3nuiR+UF5xOTMSh61w3pYXBvbFzEhNzyAafsSEx6+GekSnbfIo9YxumqjgDFdUcEL0OkWvPxCF6HWJykD0KkR1OpR9jJHv2odoHEVbze8E66HRgGhCRL9hrxgz3PQXVyEayt45EB2f/7FKmeUOzTxEkySqBfx4z7F5irJQGvYQ/VzV3VcTpIMrGKMQvaqZkcXYfhuiCVq9WEz2kSGKDgNEIXpVosao27tG7ocA0QiLBkTFE9ERN+BOKqp5vG3Q+Ntzp8x6k9V5E6LTjlH/IJQxqr3LfmGEOp5z1Ew/1GsQnUF0g6xsyanJMVon2rSMRcN2XjoNec+B3A9hsodIV8MVZbeaeoM9TKboSiiiCyM35haiXtN5U9JtVXVzixkpuphalCXY6wYdb0KnXNkgK1xR86G2DdHpRTUiem6nuRL1G0rUkm/dlvdbBu5kb9Fm7Kk8WDNUUdbjxWiIrob8APMWLbPsQDRdKn8SlfdbTixqtPsIoYqydB6iM1TdoGH80c6pqrteY7mlzEBU3m8ZuJPNjbQ/MbZZflwOWfTHTiREWTRFL5wZfUX2fU67UvSI6LXz/UBU3m8p90OYaF4kVkEb9DDEJ50jYp7FIDpbhyFrx7hlBFGI3gDReAeiEIUoRCEK0bGi/aUjRCEK0YiKsgWIQnQK0cGOQSrTvc0PotETrRB1wxHVgnC7FBu0zXrD2+VAdDLRvGGFI2p0190wn/Nm84i9M/MQnVo0u6Q2k5J3Muhkm/2toTozvAryloNQ8+rTTe4QHSV6e/VM7ijRTLG/mZTTZnXXk1tDZe3c4vQPkepmq+E+638yc7Jb0SA6LErcVZtJPeNyoxN6qTYSmqX2ph1+EOqT1oWmWYPo1GNUznW9RqBE28ycWVScSTuhPumX8lMBojOJys2kBOfRof5Rbg01U9Vl7H051JmRy9K7emLH6GW3IRszM5Ki+9xx98TMyOF/4PRutplRWnxjmGkRvfUicgd2nEQTkRiKng5EIQpRiEIUohC9jOjUqxmIXlJ0dRWisRLt7yJ3dLxYgmjsRdUucmbtuDM94oAQjZeo2kXOrJnXJTp9kwGi46P2HGO9X5vXJ7qyDNGwRdO1nxujd5GDaAyr7r7cu1PLX88YneFd3xD9/MzIytaOL/XEQJSSnVBWL5bm8THn0dt3IiWKXHbQQxSi0y5J+59XQAtRBKIQVY3d4duzIArRiZoM4f5CS2T8Ave46t6GKESnqb1KE6IQRSAKUYgmTfSsLEQhOu3iFIEoAtFk5TVEE5XUR+pCNEnx90p5iCZKdLNWnElUtevnLArSGdLyDiGaqBj0bKaqqzJnUZTdWaI90V2IYj0K0QiP0V+fNyCapGToQwGiiVq9/PZvxeiKLo9RXViG3uj16AeIJiqVFy+qEE1SdCIXoonKmw8Mooma6zbTh9EUPfeLYkcEfiPOo2/XihBN1HKU6BLr0XNB1Y2CaBeiScrmD2uzz4zmXYYhevmlzKFazxQgGt+c6tSrXeQ+/eoKiMbzRDrUqVe7yDGWakdEdPxcGKIjc6pT399Fjj1mEI2x6HCnvi+qbbMLd5GDaPQ7DMOderWLHNOrMRmjaDCMnt4OderVLnJsvQ3ROGe4U692kWP/YRCNc+61o9thgOgMyRF3IZqktEpBPpaiC7j4csHqpZ0uhig69y2sIPqZaJs7a7VYijLc/DkyR0QUYtUdym2IQhSiYVTdtbW1MkRvSiAay0H6yy8diCYpKZxHk9Zh8L47gGiiOgzrO7X4ii4sQ/Cc6OZfixBNUipPCGM0WXNd9rwM0SSBarHuMED0XI4qc1u9rM790tq5NzbBF6KoutPkCi5/n666qMFsnp16iF5T1Z3b1TSIQhSioVTdytsvDyCapPiuWYiv6Djfm5rWo/cQTVSyl9mHAaJRzJuPDKI3JfEWXQEwRCH6GdE7EIUoRKMsehui1xP9IDGiK1MlmeDa2v/Zu5veto08DOBThKJImQcPYFIvzmGRTxDAX4AC5A3s5EACjmshe6ABGwV2LxSQOt10DxJQ77ZBDxQQHXb3YgJOukAuMpAgRU8KsNgFiv1QO6T8IjXiSLYsc2b0PEWRqoytMX+e0Qxf/mw8vjqum9YcI48uKjNAVMLUx47UD2uO/eRK2kfHM23UVXRQLoyJpjXHTI9AVN4Y1dFRN61QteLTCKLy5l+jM6NU1Dox125acwyigiWtOaaHpKJCH73eWkfRpDXHjIq+A1FVlqZpzbF9uw1RNQNRiEI0/8z1/NEpohsPIXr3mev5oxAVMHM9f1TqYVdZ0XmePwpRATPX80chKuQSdI7nj0JUxMzz/FGIipitCKJK5Xarmkslqmi95U4t3oGoUqKRns/qZSP/n11N0dLB1poLUZXWo5TSKkQhClFhwyuWMrfoxpRA9I4DURmzfbA4UW428h94Ff0ctb+BqFqfo1/Rty5EVYoZ0z2IKhTLt//ShKhKn6O1A9LIQ5RAdEF9tJ3TXFdo0QcSc5faxilEVRKtv25UIaqQaIlSWoGoYqIDiKo06m5/11jemdHUqDYPhihErym6IerJmfNRF6IQzT9anqLiDssSi3547EJUKdFf6q8bV6bDKnKUrkJUWtH9CVXkKuijGQvWQuR89n9EEy1+XkUOouOiGttFXpafeKLJEYarUTetOUboLVW/UaaPdrL9BBQl2sjUaChKLO9WqsipJHpWa39Jw0LU7NL7dbfeqNFfabtDTwtxWTjQVtkdGXV7yR/GKvrouKgeroRfak0mSsxKIrquO9YJIbuFcFO0Xlqg9GRsZuSYYTEURvTeQyFE2XTDa5L/JaKdKBFdM1ZN7wl1CpE1EEy0c/D7ytjqxTHimgvR34j2CWmSb5motksuRV+6R4Uo2SRUuq6W2xlveUT1PXOwa+wx0c0+qUdnQ9F3xm4hOG4LJlp/9mENolNnRp/s4CkN0plRWaetoehxbbfgO6LNjBZZK0UV0WGaRJIssFbK/KK8PBRXVNijhxC9469TX5R3U/E9iEIUohCVUXSBFZMVEL158ttlC6yYDNFcssiKyTlZ559cH5S5yIrJEM0ji6yYDNE8IvRRQIjeJCIfBeSKbkBUxvWonKIkT1HB16MQVW09CtElWo9CVKn16L27OqEmn6ik61GIqrceJRsCD7tYj0L09mK6BKJKiRb6EFVLdOXfDReiSs11R+8flUqUQBSiyyCqaQ1ZR12ITozYtVIgev2M10qBqPyi47VSICq/aBGiqs11x2qlQPS2RB88ePA7AdsFUelFh1XkyL4LUakH3qsMq8iZPkRVER1Wket0ISqzaGNkZpTWHNOadYhKLGqNrl5S0VKQiApRRQ6iN/noHK/d2WM98/LB3uijUooejIy6aRU5QjDqyixaGhVNq8hBVG5RnB+FKETFFsUZb+XWo1omKETl7KOjNbAhqoDoWA1stUQ3llN0rAY2RBUQFboGNkRvsnoRuQY2RG8Qee82hGhGpL3bcIbHl07JQxVFpb6mHqITcibxUcB5R+V7EIUoRl2I3n1KbeMUoosQHa+g3L679ejrRlVRUbKUoiVKaQWiCiURHUBUpWx/1yAQVSny1jOC6OTIW88IopMjbz0jiGasXtQ9ZgRRiCoRhY8CziO6Ia+3xNcCQnTyXFfeawEhOjESXwsI0YmR+FpAiE6e68p7LeDcorletbKwSHwtIEQnR95rAReZDbGfEMTNVgRRpUQtagcjQ/BpskK12xCVV7RTi3euXiQ1x4zn1glEJRaN9KvVy7DmGCn2ISqvaOlga829eJFWqCKW7S69KBH9hmPOepReFqS6ECVWKEXNMYhOF01rjrFP0lX0UXlFtUaj4Y7OjBx9UAwhKq8o0VwytnpxjLiGz1GZ++jynh+9hqjpXS3gB4K3e4nPj84q+gV1ZBJd4vOjM4u2Oz9IJLrE50dnFy383evQUyN2TL9pvam521Rg1iU+Pzq7aHeL9dHdzeDHY7f35LQ0eKE1xW33Ep8fnf1ztGl6T6jTSR9K9mRgehXyUeCG4/zo9D7K5rov3SMm+sfkc1Q/EVp0ie9kupboOyMZdTvRKyvcDl4YAo+6S3wn07VEj2u7hu/o/n3LLxOhZ0ZLfCfTNY4wyJQlvu8FohCVIkt8J5Oiov8MMDNSSnSF1iCqlGjhWSuC6GTRvKt/3nBiNKj3IaqU6Pv6e8yMbpp7IopSrF4giogsOnYpIEQVEOUGohCFKEQhClGIQhSiEIUoRCEKUYhCFKIQhShEIQpRiEIUonMkrSJnxLU2RBURTavImc9LIUQVET2vIqcPIKqI6HnNsUf4HFVM9DlBFTllRt2kity2iz6q0szIMfawelFq9eLol9d7QnSaqGwPLYAoRBGxh2OIQhSBKEQhClGIQhSiEEUgClGIQhSiEIUoRBGIQhSiEIUoRCEKUQSiEIUoRCEKUYhCFIEoRCEKUYhCFKILF/3stok2RCEKUQSiEEUgikAUgSiSnbSKHDFXIapK0ipyxIeoMhlWkTMgqkyGNccgqqQoqsgpMur2MOoqNzNyIKrY6sUhPg0hqmYgClEEoghEEYgiEIUoAlEEoghEEYhCFIEoAlEEoghEIYpAFIEoAlEEohBFIIpAFIEoAlGIIhBFIIpAFIEoRBGIIhBFIIrMnGEVuf2aC1FFklaRMyrFEKKKJK0ip4eGB1FFktYcswbaGkTVE02ryCG3ltxG3V4y6pozjrqr802V5/xysVu3Ks7MyJl9ZgRR4UWHVeRmXr1AVHhRqfYZRCEKUYhCFKJii65M2d7P9cvFbl0fRzcQBEEQBEEQBEEQZBjD3+Nu1y+e9DN5CR6SHn2evf0j0VoXJ3k+j+mXXVL0stsW19wi5/1f0VP2bzv77b/mt67o8VpnUPbW3NZVSKssnmghOORu/4Wzw4jGfub/aLuZ2+tlYp2UMkmsYDMgH7L3md7f7h82sr/9n7R32jPe79tTbuvYW/Nalz6HjNO6zT7Rd9gPIFo65AuuWYXfg5P98efs7V8RK1wZcHpJpO96nO+/GR2x75HduuYKbwQ5POS2jr01r3WJKK91H1nzAz0UTrRHChFns2nTwRRRI+CJam/+62Zv/ys53uKIFsqkSf6Rvd0PS76d+Qtp7PS4rWNvzWudQWsur3Vv6F4hMk+kE90xmlNEnxCeqB4eZu9TbaDtmbw+uh1wRbW3hb6VuU832z1e65K35raObD/nte4Z+VVI0Q6p80ZdwyNHfFEj5IoW2pyd8rdk+kFd3vc/Ska37O9fDC4fu/n5j0bpGqd1yVtv8lpH9G94rTsinWKwIt6oO2VmpO0aFb7oocsVLYXFzB9a30lGgexdWmQzJ97M6Ejb1XeKIW8A4rbO9Hits4LtgNe6Q/eFkDOjaauXYxrw5ro0aFE7e65LnWQFkilGqcfbZ7pfJrzVyyHbxll+JKK81rG35rWOra34v29s7STi6gVBEARBEARBEARBEARBEARBEARBEARBkPlyFs74F+MAO0vIdGqk61y8WCmPi7aC2UT99vl/dD3Dxj7NWZRGcabotfto18Mezb+PvrUdsk/7pXJ8uk+rZz/ZbT250Etr0bAVpC99m71ggN0/VLt0ncQva+4j6gePaJO0vi73ysT/ntJqidbYHz/byV0upv3Jwb7NSbRKXzorZWu9tF5ykj56chbun7ANxfVk1E1fhqRYKVSYKK0SzY/ifhy0gjj5J2r1/b7fZqNul/XtfS8ZdU3brJn2FkbfvETX4ldOoWraJae4no66+yfd2s+EWPRbl4myl3FE6pQ66Zj6mFIm2XpP3fiAumeDoazf1p66ZoumotZ9jW7ZBu+SbmShoqT0W1H9U8LxkXpXomvnn5KtMJ4ourlHOntdiIoimo66TFQfihIt5eiei7JRt1RO7i5jovGBn4iycdcfjrrnoq2Ibd33OpejLkRzFU1nRkxUi6sJ4Rmb8pASLbeHosnM6FNyTy8T7dlD0WP7fGY0FP2BjcpFGnvFy5kRRBEEQf7f3vm0tnGEYfwNrGZ3oz1kwKuN1HwYCSJauz5oQRVWk8P6IEzTywoSh5QeVhAljelhBRW0PdngJi3uwTk0htCDfWhCTD5UZ6QmKaH7yH+KHLXPD3R6Z1Y785vZv69GhBBCCCGEEEIIIYQQQgghhBBCCCGEEEIIIYQQQgghhBBCCCHk9Pjh2WLkw6FRk35eaK08/d89FdHo4hjVyWyjnKOLZDRu93O7fkh8VFmv+GG/atdcG92s2j8Gvb1u1+nST59FXl9/ESr+U+YiGL0R/WX0O/196IefhHbNNbvimoh7zc5RY/ZZVKqaOTraZX8tgNFWHE+N3tf39aNQ4pHWlckqlj0dTY1mKirpF374dtlS8kEbHen3jC5N1yVVtU/fGXWe61daH7K/FsGoq/Ojw503Rv3QrrlmjZYjN1JvjIocvQqHVfbXIhh14nwYvTWqf7Zrrlmjzk4tcnaqU6MNHS2HKqyzwwghhBBCCCGEEEL+V5Ty9/+IKDhkrywcjta69caonNHoHRG3VRy2sTuwuqvTwuiW3jWfrCjsx1G9r7WguByAbz8QT4OvL6e4cWbTffTaWOm1eTsdvJujZzRa/kzkN9BoE7NFQPXe9U5h+Etnz7lRXDtImonISxhvgC43Me8KGvEpbJyprtp2D4oYZr36/I2Ow/w43i3l3ZG+1qg3rtf0sc4Gejf4qXaSven1RHWKG21jpgiqvikboFO75RR9vZuLs4TjYOsmhoyKSmHjTHU3USmKl7K5G/Xafvu4/qsxKv5Va/QjVQm2RTrB7uUTzFKvPZbhcnGjTcwWQdW78mPx9uP0chyCXnlgpKHdfCCzjGowcI0t1DhrLPe3i+PjrJnP3ajSeum1jK3RQW6NLnlX/NaqrgSHfmv2BprZ2FkrLmhjpgiqjo06j0v7QXGfOcbmABxKbBwbFVlJgVHUuNlGAx1fgFGzQ6/lljHqdOSt0a/qm8Gh2j7BBrSumuurok411x16ZMYMqL60Ca9dNtwEHBgfms/XoPZDmW1UIaMeaNz0qIvPCoP5n0e9qrf90syEvNvcl0b+dGp0z+sE6Upykk2YCYiGsY2NYXV0ZbTpdFTbLewz1bYHbnAebM80GiSgmVY2nqP4yki8vQu41u3pwz90OrkyipTuT40Oa50gPlk657mNoruXnon1i090rrn7KoEetfGGLv7LXxPzQTPN3V2CGmc3De9eXJ3IhfCat+b/MWiUEEIIIYQQQsi8+dsjkZM8mScfNpd05ZxGvZ1afaxvF8ZNzBYpjJdT+ViD3xofCMphsNUHGjyHs4/R0XsAWUev6mwSRAU2X4EnmJPumfcP+i5lg0fnM6r2V/ZfOMWP2k3MFikK2yyBY3lSWL0RCcphsNUHguMoh0G8NdVGzWvkI2j8eYa7pzl/o6UfWgO96+1U/Ljrfx5mK6f+4a99p3sPxO9NixSNiFReyu/FtTcEvq1S2Ojk5ckGjsNMoEbWqKMRcxX3jdPpzt3oyL6i7zSTb4f18fJauXXXOeU+lMwU8BIwC5JJEdClKzdvI6Mwh8EaRQftWUb9NdxeP/oFhkM8Adz9uRvV3Um+ghnn61ovt5ylq/i08w+sJLIKwqvTIqDLN1QHGYU5DNaY8+TsRuUohMfF5jd30Bz12x5UdiDzn6MyyVcwRm/Z86h3BqMq9cBxcRKDWQLmsDdGRmEOw2TLG+cwKh7KO5uknaDKLdlE1ftzX71iYnTPs0fdQb7lt4L0rne6UeUmzQRlMJqYmzThHH0id1GXohwGW/2F8/g8Rrf2UXSUDTJ4nvRmnEkvZI4Oax0vrqj4mh/X6qe9MlJxZEZiCEZpqGZkCWyBE+EkS6D45sdWH4MbCBtHOQxm/2bdneD4cFaSwryNEkIIIYQQQgghhBBCCCGEEEIIIYQQ8m/yJ1XV7R5pplgvAAAAAElFTkSuQmCC"/></div><div class="graphic_lgnd">Shown are Kaplan-Meier estimates of the proportion of participants in whom clinical diabetes was not diagnosed. The overall hazard ratio was 0.41 (95% CI 0.22-0.78; two-sided p = 0.006 by adjusted Cox proportional-hazards model). The median time to diagnosis of type 1 diabetes was 48.4 months in the teplizumab group and 24.4 months in the placebo group. The numbers of participants with or without a diagnosis of clinical type 1 diabetes (upper right) represent data at the conclusion of the trial. Tick marks indicate censored data.</div><div class="graphic_reference">From: Herold KC, Bundy BN, Long SA, et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 2019; 381:603. Copyright Â© 2019 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.</div><div id="graphicVersion">Graphic 81644 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
